These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20631685)

  • 1. Dopamine transporter (SLC6A3) genotype impacts neurophysiological correlates of cognitive response control in an adult sample of patients with ADHD.
    Dresler T; Ehlis AC; Heinzel S; Renner TJ; Reif A; Baehne CG; Heine M; Boreatti-Hümmer A; Jacob CP; Lesch KP; Fallgatter AJ
    Neuropsychopharmacology; 2010 Oct; 35(11):2193-202. PubMed ID: 20631685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SLC6A3 gene polymorphism is related to the development of attentional functions but not to ADHD.
    Kuc K; Bielecki M; Racicka-Pawlukiewicz E; Czerwinski MB; Cybulska-Klosowicz A
    Sci Rep; 2020 Apr; 10(1):6176. PubMed ID: 32277231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dopamine transporter gene (SLC6A3) variation on dorsal anterior cingulate function in attention-deficit/hyperactivity disorder.
    Brown AB; Biederman J; Valera EM; Doyle AE; Bush G; Spencer T; Monuteaux MC; Mick E; Whitfield-Gabrieli S; Makris N; LaViolette PS; Oscar-Berman M; Faraone SV; Seidman LJ
    Am J Med Genet B Neuropsychiatr Genet; 2010 Mar; 153B(2):365-375. PubMed ID: 19676101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies.
    Bonvicini C; Faraone SV; Scassellati C
    Mol Psychiatry; 2016 Jul; 21(7):872-84. PubMed ID: 27217152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional genomics of attention-deficit/hyperactivity disorder (ADHD) risk alleles on dopamine transporter binding in ADHD and healthy control subjects.
    Spencer TJ; Biederman J; Faraone SV; Madras BK; Bonab AA; Dougherty DD; Batchelder H; Clarke A; Fischman AJ
    Biol Psychiatry; 2013 Jul; 74(2):84-9. PubMed ID: 23273726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the dopamine transporter (SLC6A3/DAT1) gene 9-6 haplotype with adult ADHD.
    Franke B; Hoogman M; Arias Vasquez A; Heister JG; Savelkoul PJ; Naber M; Scheffer H; Kiemeney LA; Kan CC; Kooij JJ; Buitelaar JK
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1576-9. PubMed ID: 18802924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 40-bp VNTR polymorphism in the 3'-untranslated region of DAT1/SLC6A3 is associated with ADHD but not with alcoholism.
    Šerý O; Paclt I; Drtílková I; Theiner P; Kopečková M; Zvolský P; Balcar VJ
    Behav Brain Funct; 2015 Jun; 11():21. PubMed ID: 26058807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between a 3'UTR VNTR polymorphism of dopamine transporter gene (SLC6A3) and ADHD in a Brazilian sample of adult patients.
    Aparecida da Silva M; Cordeiro Q; Louzã M; Vallada H
    J Atten Disord; 2011 May; 15(4):305-9. PubMed ID: 20332413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder.
    Roman T; Rohde LA; Hutz MH
    Am J Pharmacogenomics; 2004; 4(2):83-92. PubMed ID: 15059031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analyses of dopamine related genes in adult ADHD patients suggest an association with the DRD5-microsatellite repeat, but not with DRD4 or SLC6A3 VNTRs.
    Johansson S; Halleland H; Halmøy A; Jacobsen KK; Landaas ET; Dramsdahl M; Fasmer OB; Bergsholm P; Lundervold AJ; Gillberg C; Hugdahl K; Knappskog PM; Haavik J
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1470-5. PubMed ID: 18081165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tph2 gene variants modulate response control processes in adult ADHD patients and healthy individuals.
    Baehne CG; Ehlis AC; Plichta MM; Conzelmann A; Pauli P; Jacob C; Gutknecht L; Lesch KP; Fallgatter AJ
    Mol Psychiatry; 2009 Nov; 14(11):1032-9. PubMed ID: 18427560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further evidence for the association between a polymorphism in the promoter region of SLC6A3/DAT1 and ADHD: findings from a sample of adults.
    de Azeredo LA; Rovaris DL; Mota NR; Polina ER; Marques FZ; Contini V; Vitola ES; Belmonte-de-Abreu P; Rohde LA; Grevet EH; Bau CH
    Eur Arch Psychiatry Clin Neurosci; 2014 Aug; 264(5):401-8. PubMed ID: 24487615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of an association between 10/10 genotype of DAT1 and endophenotypes of attention deficit/hyperactivity disorder.
    Agudelo JA; Gálvez JM; Fonseca DJ; Mateus HE; Talero-Gutiérrez C; Velez-Van-Meerbeke A
    Neurologia; 2015 Apr; 30(3):137-43. PubMed ID: 24461309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder.
    Mazei-Robison MS; Couch RS; Shelton RC; Stein MA; Blakely RD
    Neuropharmacology; 2005 Nov; 49(6):724-36. PubMed ID: 16171832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHD.
    Kambeitz J; Romanos M; Ettinger U
    Pharmacogenomics J; 2014 Feb; 14(1):77-84. PubMed ID: 23588108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine transporter 3'UTR VNTR genotype is a marker of performance on executive function tasks in children with ADHD.
    Karama S; Grizenko N; Sonuga-Barke E; Doyle A; Biederman J; Mbekou V; Polotskaia A; Ter-Stepanian M; De Guzman R; Bellingham J; Sengupta S; Joober R
    BMC Psychiatry; 2008 Jun; 8():45. PubMed ID: 18559107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An association between a dopamine transporter gene (SLC6A3) haplotype and ADHD symptom measures in nonclinical adults.
    Tong JH; Cummins TD; Johnson BP; McKinley LA; Pickering HE; Fanning P; Stefanac NR; Newman DP; Hawi Z; Bellgrove MA
    Am J Med Genet B Neuropsychiatr Genet; 2015 Mar; 168B(2):89-96. PubMed ID: 25656223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate.
    Joober R; Grizenko N; Sengupta S; Amor LB; Schmitz N; Schwartz G; Karama S; Lageix P; Fathalli F; Torkaman-Zehi A; Ter Stepanian M
    Neuropsychopharmacology; 2007 Jun; 32(6):1370-6. PubMed ID: 17063150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dopamine transporter gene and the impulsivity phenotype in attention deficit hyperactivity disorder: a case-control association study in a Korean sample.
    Kim JW; Kim BN; Cho SC
    J Psychiatr Res; 2006 Dec; 40(8):730-7. PubMed ID: 16368111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1).
    Kooij JS; Boonstra AM; Vermeulen SH; Heister AG; Burger H; Buitelaar JK; Franke B
    Am J Med Genet B Neuropsychiatr Genet; 2008 Mar; 147B(2):201-8. PubMed ID: 17955457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.